An epidemic CC1-MRSA-IV clone yields false-negative test results in molecular MRSA identification assays: a note of caution, Austria, Germany, Ireland, 2020
- PMID: 32613938
- PMCID: PMC7331142
- DOI: 10.2807/1560-7917.ES.2020.25.25.2000929
An epidemic CC1-MRSA-IV clone yields false-negative test results in molecular MRSA identification assays: a note of caution, Austria, Germany, Ireland, 2020
Abstract
We investigated why a clinical meticillin-resistant Staphylococcus aureus (MRSA) isolate yielded false-negative results with some commercial PCR tests for MRSA detection. We found that an epidemic European CC1-MRSA-IV clone generally exhibits this behaviour. The failure of the assays was attributable to a large insertion in the orfX/SCCmec integration site. To ensure the reliability of molecular MRSA tests, it is vital to monitor emergence of new SCCmec types and junction sites.
Keywords: BD MAX, next generation sequencing; CC1-MRSA-IV; Cepheid GenXpert; Staphylococci; Staphylococcus aureus; commercial PCR.
Conflict of interest statement
Figures
References
-
- The European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST rapid antimicrobial susceptibility testing (RAST) directly from positive blood culture bottles. Version 1.1. Växjö: EUCAST; 2019. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/RAST/EUCAST...
-
- The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Zone diameter breakpoints for rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles. Version 1.1. Växjö: EUCAST; 2019. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/RAST/EUCAST...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical